# Coenzyme Q10 Migraine Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/coenzyme-q10-migraine-meta-analysis-evidence-review
Category: evidence-review
Summary: Coenzyme Q10 Migraine Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mix
Last reviewed: 2026-05-21
Reviewed by: Migaku Evidence Review
# Coenzyme Q10 Migraine Meta-analysis: What the Evidence Says

## Quick Answer

Coenzyme Q10 Migraine Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Dietary Modulation of Migraine: Metabolic, Neuroinflammatory and Microbiota-Mediated Mechanisms | narrative review | 3 | 2026-02-13 | 10.3390/jcm15041476 |
| Energy metabolism disorders in migraine: triggers, pathways, and therapeutic repurposing | narrative review | 3 | 2025-04-02 | 10.3389/fneur.2025.1561000 |

## What The Sources Report

- Migraine is a chronic, disabling neurovascular disorder characterized by recurrent episodes of moderate-to-severe headache, typically unilateral and pulsating in quality, and frequently associated with nausea, vomiting, photophobia, and phonophobia. [Santangelo Domenico (2026); evidence level 3]
- These processes result in peripheral and central sensitization of nociceptive pathways, thereby amplifying pain perception and contributing to migraine chronicization. [Santangelo Domenico (2026); evidence level 3]
- A growing body of evidence points to a significant link between migraine and disruptions in brain energy metabolism. [Sun Wen-xiu (2025); evidence level 3]
- As a result, prophylactic treatments for migraine that target brain energy metabolism, including riboflavin, coenzyme Q10, alpha-lipoic acid (ALA), and ketogenic diet (KD), have gained increasing attention. [Sun Wen-xiu (2025); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For coenzyme q10 migraine meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Santangelo Domenico (2026). Dietary Modulation of Migraine: Metabolic, Neuroinflammatory and Microbiota-Mediated Mechanisms. DOI: 10.3390/jcm15041476. PMCID: PMC12942355. PMID: 41753160. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12942355/
- Sun Wen-xiu (2025). Energy metabolism disorders in migraine: triggers, pathways, and therapeutic repurposing. DOI: 10.3389/fneur.2025.1561000. PMCID: PMC12002086. PMID: 40242623. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12002086/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.